Matches in Wikidata for { <http://www.wikidata.org/entity/Q65351087> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q65351087 description "clinical trial" @default.
- Q65351087 description "ensayu clínicu" @default.
- Q65351087 description "klinisch onderzoek" @default.
- Q65351087 description "клінічне випробування" @default.
- Q65351087 name "A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)" @default.
- Q65351087 name "A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)" @default.
- Q65351087 type Item @default.
- Q65351087 label "A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)" @default.
- Q65351087 label "A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)" @default.
- Q65351087 prefLabel "A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)" @default.
- Q65351087 prefLabel "A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)" @default.
- Q65351087 P1132 Q65351087-1F06AA2B-0971-4A89-AB9D-380E5CD75770 @default.
- Q65351087 P1476 Q65351087-BE7BA45D-B88B-46AF-9DD1-AFF171205C52 @default.
- Q65351087 P17 Q65351087-4C8387F0-9369-4BD9-81EA-509924DFB540 @default.
- Q65351087 P17 Q65351087-7A1BDFAB-E1C0-4B30-8313-2754589CBE7D @default.
- Q65351087 P2899 Q65351087-03EFFEA7-FFE4-419B-AC35-BE31D58CA3EB @default.
- Q65351087 P3098 Q65351087-06808DC7-CDDC-4DF9-9242-A9E0C8D46631 @default.
- Q65351087 P31 Q65351087-50FF7D2C-BAB2-4C4F-AD6E-39E46E0AFDDB @default.
- Q65351087 P580 Q65351087-8B48CBC7-3B6D-43FD-97E1-027E1E7AA716 @default.
- Q65351087 P582 Q65351087-E52F9151-4E21-4B6B-924B-EFF19674968B @default.
- Q65351087 P6099 Q65351087-304F4A83-507B-43AF-9A80-3590206678AD @default.
- Q65351087 P6099 Q65351087-364684DE-478D-4F7C-BC58-9E8433A8CA06 @default.
- Q65351087 P6153 Q65351087-033E4AE0-46B2-48B7-A0B1-8BBE59F96C4E @default.
- Q65351087 P6153 Q65351087-222ECD8B-C0C3-42CE-8041-7C91EAA0C21D @default.
- Q65351087 P6153 Q65351087-25184482-D770-4456-842E-E64E80297073 @default.
- Q65351087 P6153 Q65351087-2ADF3D79-506A-4132-B093-C6D19B0DD2B5 @default.
- Q65351087 P6153 Q65351087-41701247-DA3D-48D7-AB5A-C5B0EFB31FFB @default.
- Q65351087 P6153 Q65351087-42300381-0EB9-4072-9D5A-15B1725BF1CB @default.
- Q65351087 P6153 Q65351087-51E6F109-0445-4BC4-9CB1-397566FC3A35 @default.
- Q65351087 P6153 Q65351087-C25E2D71-8DBD-41FF-8A07-CB4181C6CA5D @default.
- Q65351087 P6153 Q65351087-FEEBFD12-B9EB-4FDA-83FA-D033BCEB2146 @default.
- Q65351087 P767 Q65351087-62DCDB8A-3D0B-44D4-86AF-430831AB89F8 @default.
- Q65351087 P8363 Q65351087-B2077A61-22AA-4F96-8251-2D2828DEED3D @default.
- Q65351087 P1132 "+307" @default.
- Q65351087 P1476 "A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)" @default.
- Q65351087 P17 Q145 @default.
- Q65351087 P17 Q30 @default.
- Q65351087 P2899 "+18" @default.
- Q65351087 P3098 "NCT02327078" @default.
- Q65351087 P31 Q30612 @default.
- Q65351087 P580 "2014-11-01T00:00:00Z" @default.
- Q65351087 P582 "2020-04-01T00:00:00Z" @default.
- Q65351087 P6099 Q42824440 @default.
- Q65351087 P6099 Q5452194 @default.
- Q65351087 P6153 Q1159198 @default.
- Q65351087 P6153 Q16976147 @default.
- Q65351087 P6153 Q30279912 @default.
- Q65351087 P6153 Q30282030 @default.
- Q65351087 P6153 Q30288565 @default.
- Q65351087 P6153 Q5110676 @default.
- Q65351087 P6153 Q56582915 @default.
- Q65351087 P6153 Q6806307 @default.
- Q65351087 P6153 Q7914455 @default.
- Q65351087 P767 Q266423 @default.
- Q65351087 P8363 Q78089383 @default.